Kenneth Marek

6PUBLICATIONS
70CO-AUTHORS
Autonomic nervous systemNeurology and neuromuscular diseasesCognitionPharmacogenomicsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2025
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease.

David G Coughlin, Ben Shifflett, Carly M Farris

|Sep 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.

Tien Dam, Gennaro Pagano, Michael C Brumm

|Aug 07, 2024
LRRK2-Associated Parkinsonism With and Without <i>In Vivo</i> Evidence of Alpha-Synuclein Aggregates.

Lana M Chahine, David-Erick Lafontant, Seung Ho Choi

|Feb 02, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.

Katheryn A Q Cousins, David J Irwin, Thomas F Tropea

|Feb 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.

Tanya Simuni, Michael C Brumm, Liz Uribe

|Aug 17, 2018
Finding useful biomarkers for Parkinson's disease.

Alice S Chen-Plotkin, Roger Albin, Roy Alcalay

Pageof 1

Frequent Collaborators

5 joint publications

Kathleen Poston

5 joint publications

Michael C Brumm

4 joint publications

Brit Mollenhauer

4 joint publications

Andrew Siderowf